Omnitus - instructions for use, analogs, reviews and release forms (20 mg and 50 mg tablets, syrup) antitussive drug for the treatment of dry cough in adults, children and pregnancy. Composition

In this article, you can read the instructions for using the drug Omnitus. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of Omnitus in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Omnitus in the presence of existing structural analogues. Use for the treatment of dry cough in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

Omnitus antitussive drug of central action. Butamirate citrate (the active ingredient of Omnitus) is neither chemically nor pharmacologically related to opium alkaloids. Has direct influence on the cough center. Has expectorant, moderate bronchodilating and anti-inflammatory effect. Improves spirometry and blood oxygenation.

Composition

Butamirate citrate + auxiliary substances.

Pharmacokinetics

After ingestion, absorption is high. Butamirate citrate is rapidly hydrolyzed in plasma to 2-phenylbutyric acid and diethylaminoethoxyethanol. Both these metabolites, which also have antitussive action, largely bind to plasma proteins, which explains their long-term presence in plasma. Subsequently, the main metabolite 2-phenylbutyric acid is oxidized to 14C-p-hydroxy-2-phenylbutyric acid. Do not cumulate. All three metabolites are excreted by the kidneys, and the acid metabolites are mainly in the form of glucuronides.

Indications

• dry cough of any etiology (for colds, flu, pertussis and other conditions);
• to suppress cough in the preoperative and postoperative period, during surgical interventions, bronchoscopy.

Forms of release

Modified release tablets coated with 20 mg and 50 mg capsules.

Syrup (sometimes mistakenly called a drop or solution).

Instructions for use and reception scheme

The drug is prescribed inside.

Tablets 20 mg

Adults appoint 2 tablets 2-3 times a day; children over 12 years - 1 tablet 3 times a day; Children aged 6 to 12 years - 1 tablet 2 times a day.

50 mg tablets

Adults take 1 tablet every 8-12 hours.

Tablets are taken before meals without chewing.

Syrup

Adults appoint 6 measuring spoons (30 ml) 3 times a day; children older than 9 years (body weight from 40 kg) - 3 scoops (15 ml) 4 times a day; children aged 6 to 9 years (body weight 22-30 kg) - 3 scoops (15 ml) 3 times a day; children aged 3 to 6 years (body weight 15-22 kg) - 2 scoops (10 ml) 3 times a day.

Side effect

• nausea;
• diarrhea;
• exanthema;
• dizziness;
• allergic reactions.

Contraindications

• lactation period;
• hypersensitivity to the components of the drug.

For tablets:

• pregnancy;
• Children under 6 years of age (20 mg tablets);
• children and adolescents under 18 years (tablets 50 mg).

For syrup:

• 1 trimester of pregnancy;
• children under 3 years.

Application in pregnancy and lactation

Contraindicated use of the drug Omnitus in the form of syrup during pregnancy, in the form of tablets - in the first trimester of pregnancy.

If you need to use the drug during lactation, you should decide whether to stop breastfeeding.

Use in children

Contraindication: children under 6 years (tablets 20 mg); children and adolescents under 18 years (tablets 50 mg), for syrup - children under 3 years.

special instructions

During the period of treatment, it is not recommended to prescribe drugs that depress the central nervous system (including sleeping pills, antipsychotics, tranquilizers), patients should not consume alcohol.

Be wary appoint patients with kidney failure.

If the patient began taking butamyrate without consulting a doctor and after 3-4 days of treatment cough does not stop, you need to see a doctor.

Patients with diabetes can be prescribed a drug, because As a sweetener in syrup, sorbitol and saccharin are used, the tablets contain lactose.

In 1 ml of syrup contains 0.003 ml of ethanol (alcohol). When receiving the recommended single dose, the patient receives 0.03 ml of ethanol in 10 ml of syrup. It should be taken into account that this poses a danger for patients with liver diseases, alcoholism, epilepsy, brain diseases, as well as for pregnant women and children.

Drug Interactions

The drug interaction of Omnitus with other drugs is not described.

Analogues of medicinal product Omnitus

Structural analogs for the active substance:

• Butamirate citrate;
• Kodelak Neo;
• Panathus;
• Panatas Forte;
• Sinecod.

Analogues for the pharmacological group (antitussives):

• Alex Plus;
• Bronchicum;
• Bronchicum cough syrup;
• Bronhitusen Vramed;
• Broncholitin;
• Bronchoton;
• Bronchocine;
• Hexapneumine;
• Glycodine;
• Grippostad Good Night;
• Kodelak;
• Kodelak Neo;
• Kodelmikst;
• Codipron;
• Codterpine;
• Co -anol;
• Levopron;
• Libexin;
• Neo Codion;
• Neo Codion for adults;
• Neo Codion for children;
• Neo Cody for babies;
• Noscapine;
• Padeviks;
• Paxelidine;
• Panathus;
• Paracodamol;
• Sedotussin;
• Sinecod;
• Terasil D;
• Terpinkod;
• Tussin;
• Tussin plus;
• Tusuprex;
• Falimint;
• Fervex from a dry cough.

Similar medicines:

Other medicines: